Wealthspire Advisors (Maryland)’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-690	Closed	-$17K	–	2740
2017 Q4	$17K	Hold	690	–	–	﹤0.01%	1387
2017 Q3	$13K	Hold	690	–	–	﹤0.01%	1488
2017 Q2	$11K	Buy	690 +540	+360%	+$7.51K	﹤0.01%	1511
2017 Q1	$2K	Buy	+150	New	+$2.41K	﹤0.01%	1748

Wealthspire Advisors (Maryland)'s ENTL Position: Q1 2018 in Review

Wealthspire Advisors (Maryland) sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 690 shares — an estimated $17K sold.

Wealthspire Advisors (Maryland) first reported a position in ENTL in Q1 2017 and held it in 4 quarters. The position peaked at $17K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Wealthspire Advisors (Maryland) reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Wealthspire Advisors (Maryland) sold 690 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $17K.
Wealthspire Advisors (Maryland) first reported a position in Entellus Medical, Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Wealthspire Advisors (Maryland)'s Entellus Medical, Inc. Common Stock position peaked at $17K in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q1 2018, filed 3 May 2018.